Journal
ONCOTARGET
Volume 8, Issue 40, Pages 69174-69184Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.20088
Keywords
NSCLC; lncRNAs; chemotherapy; radiotherapy; molecular therapy
Categories
Funding
- National Natural Science Foundations of China [81272566, 81472773]
Ask authors/readers for more resources
Lung cancer, with 80-85% being non-small cell lung cancer (NSCLC), is the leading cause of cancer-related death in both men and women. Long non-coding RNAs (lncRNAs), always defined as non-protein-coding RNA molecules longer than 200 nucleotides, are now thought as a new frontier in the study of human malignant diseases including NSCLC. As researches continue, increasing number of roles that lncRNAs play in NSCLC has been found, and more and more evidences show lncRNAs have a close relationship with patients' response to radiochemotherapy or molecular therapy. The aim of this review is to disclose the roles that lncRNAs play in NSCLC and how lncRANs influence the treatment of NSCLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available